Osteomalacia
Osteomalacia is a bone disorder in adults characterized by the softening of bones due to impaired bone mineralization. It is most commonly caused by vitamin D deficiency, which leads to decreased calcium and phosphate absorption—both of which are essential for healthy bone formation. Unlike osteoporosis, where bones become porous and brittle, osteomalacia results in soft and pliable bones, making them more prone to deformity and fractures. This condition often develops gradually and may be difficult to detect in early stages. It is frequently underdiagnosed, especially in older adults, individuals with malabsorption syndromes, and those with limited sun exposure. Symptoms may include diffuse bone pain, muscle weakness, and difficulty walking. Timely diagnosis and treatment can reverse the disease process and restore bone strength, making early recognition essential for preventing long-term complications.
Causes & Risk Factors
The leading cause of osteomalacia is vitamin D deficiency, which may arise from insufficient sunlight exposure, dietary lack, or conditions that impair absorption, such as celiac disease, chronic pancreatitis, or inflammatory bowel disease. Other causes include chronic kidney or liver disease (which interfere with vitamin D metabolism), use of certain anticonvulsant medications, and phosphate-wasting disorders. Individuals who have undergone bariatric surgery or those with dark skin living in low-sunlight regions are also at increased risk.
Symptoms
Osteomalacia often presents with vague, widespread bone pain, particularly in the lower back, pelvis, hips, and legs. Patients may also experience muscle weakness, especially in the thighs and shoulders, leading to difficulty standing, climbing stairs, or walking. In severe or prolonged cases, fractures may occur with minimal trauma, and some individuals develop a waddling gait due to bone and muscle dysfunction. Unlike osteoporosis, where fractures are typically silent, osteomalacia-related fractures are usually painful.
Diagnosis
Diagnosis involves a combination of blood tests and imaging studies. Blood tests typically show low levels of vitamin D, calcium, and phosphate, along with elevated alkaline phosphatase (ALP) and parathyroid hormone (PTH). X-rays may reveal Looser’s zones, which are characteristic pseudofractures seen in osteomalacia. A DEXA scan can help assess bone density, although it is not diagnostic of osteomalacia on its own. In rare cases, a bone biopsy may be performed to confirm the diagnosis when lab results are inconclusive.
Treatment Options
Treatment focuses on correcting the underlying cause of impaired mineralization. For most patients, this involves vitamin D supplementation, often in high doses initially, followed by maintenance therapy. Calcium and phosphate supplements may also be prescribed, depending on the lab findings. In cases related to kidney disease, active forms of vitamin D such as calcitriol may be necessary. Nutritional counseling is essential to ensure long-term dietary adequacy, and in some cases, sun exposure is encouraged under medical supervision. Physical therapy may be beneficial for regaining strength and mobility during recovery.
Prevention Tips
Preventing osteomalacia involves ensuring adequate daily intake of vitamin D and calcium, particularly in at-risk populations such as the elderly, individuals with limited sun exposure, or those with chronic gastrointestinal conditions. Regular monitoring of vitamin D status, especially in people taking medications or with medical conditions that impair absorption or metabolism, is important. Public education on safe sun exposure and dietary sources of vitamin D can also help reduce the incidence of this preventable condition.